ACKERMANS (B3K DU) stock market data APIs
€269.0477
1.44(0.5%)
as of September 10, 2026
Try our APIs with
free plan!
ACKERMANS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for B3K.DU.
Prev. Close
269.0477
Open
270.4917
High
270.4917
Low
266.2714
52 wk Range
207.8919-296.5951
Market Cap
4 993 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ACKERMANS data using free add-ons & libraries
Get ACKERMANS Fundamental Data
ACKERMANS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-28
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ACKERMANS News
New
Is It Time To Reassess Ackermans & Van Haaren (ENXTBR:ACKB) After Its Strong Multi‑Year Run?
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. If you are wondering whether Ackermans & Van Haaren is stil...
Biotalys Announces Closing of Private Placement
Biotalys NV Regulated information on the total number of voting rights and shares Ghent, BELGIUM, May 20, 2026 (GLOBE NEWSWIRE) -- Press releae - regulated information Biotalys NV (Euronext Brussel...
Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors
Biotalys NV Press release – regulated information – inside information Ghent, BELGIUM, May 06, 2026 (GLOBE NEWSWIRE) -- Public announcement in accordance with article 7:97,§4/1 of the Belgian ...
DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing
Disco Pharmaceuticals GmbH Mark Manfredi brings over two decades of international biopharmaceutical industry leadership and cancer drug discovery success to DISCO Financing will support the developm...
Get ACKERMANS fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
